Results 1 to 10 of about 154,134 (54)
Clinical profile and predictors of poor prognosis in infective endocarditis
Journal of Clinical and Preventive Cardiology, 2023 Context: Infective endocarditis (IE) is associated with high morbidity and mortality despite advances in diagnosis and treatment. A recent knowledge of the epidemiology and clinical spectrum of IE is essential for prompt recognition and effective therapy.
Bejoy V Ealias +4 more
doaj +1 more source
Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?
Bleeding, Thrombosis and Vascular Biology, 2023 A strategy of oral anticoagulants (OAC) in addition to single or dual antiplatelet therapy, known as dual-pathway inhibition (DPI), has shown to reduce thrombotic events in patients with cardiovascular disease.
Mattia Galli +2 more
doaj +1 more source
Addressing some challenges of congenital fibrinogen disorders in 2023 and beyond
Bleeding, Thrombosis and Vascular Biology, 2023 Congenital fibrinogen disorders (CFD) include several types and subtypes of fibrinogen deficiency, resulting from monoallelic or biallelic mutations in one of the three fibrinogen genes. While it is relatively easy to make an accurate diagnosis based on
Cristina Santoro, Alessandro Casini
doaj +1 more source
Open Heart, 2023 Background Tocilizumab improves myocardial salvage index (MSI) in patients with ST-elevation myocardial infarction (STEMI), but its mechanisms of action are unclear. Here, we explored how cytokines were affected by tocilizumab and their correlations with
Ola Kleveland +19 more
doaj +1 more source
Validation of the Duke Activity Status Index questionnaire by telephone In individuals after stroke
International Journal of Cardiology. Cardiovascular Risk and Prevention, 2023 Background: Due to social restrictions caused by the pandemic, there was a need to validate outcome measures that could be administered by telephone call.
Camila Dias +4 more
doaj +1 more source
International Journal of Cardiology. Cardiovascular Risk and Prevention, 2023 Background: Intermittent fasting may increase longevity and lower cardiometabolic risk. This study evaluated whether fasting modifies clinical risk scores for mortality [i.e., Intermountain Mortality Risk Score (IMRS)] or chronic diseases [e.g., Pooled ...
Benjamin D. Horne +7 more
doaj +1 more source
Oral nitrate-reducing bacteria as potential probiotics for blood pressure homeostasis
Frontiers in Cardiovascular MedicineHypertension is a leading cause of morbidity and mortality worldwide and poses a major risk factor for cardiovascular diseases and chronic kidney disease.
Xiaofen Chai, Libing Liu, Feng Chen
doaj +1 more source
Socioeconomic factors and long-term mortality risk after surgical aortic valve replacement
International Journal of Cardiology. Cardiovascular Risk and Prevention, 2023 Background: There is scarce knowledge about the association between socioeconomic status and mortality in patients undergoing surgical aortic valve replacement.
Maria Lachonius +7 more
doaj +1 more source
Case Report: Abdominal surgery with the support of Impella (SURGELLA), a new frontier to be explored
Frontiers in Cardiovascular MedicineA 74-year-old man with advanced heart failure was admitted to the hospital with a diagnosis of colorectal cancer, and he underwent surgery. To maintain stable hemodynamics, the Impella CP device was used.
Stefano Guarracini +9 more
doaj +1 more source
International Journal of Cardiology. Cardiovascular Risk and Prevention, 2023 Background: Hospital-at-Home (HAH) is a valid alternative for in-hospital stay for a wide variety of clinical indications. Occult myocardial injury, associated with acute illness, mainly occurs in patients with a background of non-obstructive coronary ...
Y. Marziano +8 more
doaj +1 more source